Le Lézard
Classified in: Science and technology
Subject: Product/Service

RSA CEO Challenges Private Sector Cybersecurity to Step Up at RSAC Public Sector Day 2024


RSA CEO Rohit Ghai will detail the new capabilities, policies, and principles that public and private sector organizations must develop to adapt to new-world cybersecurity challenges during the opening keynote of the RSA Conference Public Sector Day.

During his remarks, Rohit will explain how new government policies create a higher cybersecurity standard for both the public and private sectors, discuss the emerging risks and successful cyberattacks that have compelled the creation of those new standards, and detail the capabilities that the private sector must prioritize to address emerging threats.

"When it comes to protecting critical infrastructure, cybersecurity can't be a privilege reserved for the few, but an inalienable right shared by everyone," said RSA CEO Rohit Ghai. "To stay ahead of adversaries, secure the integrity of our elections, and build a safer world, our industry must work in close partnership with the public sector, prioritize security, embrace open standards, and reflect on why so many purported cybersecurity vendors are being breached by threat actors."

"With CISA's Zero Trust Maturity Model v2.0, the presidential mandate, and the NIST Cybersecurity Framework 2.0 (CSF 2.0), which represents the new gold standard in cybersecurity architecture, the U.S. government is teaching organizations how to enhance their security," said RSA Federal President Kevin Orr, who will host the Public Sector Day event. "What's clear across every mandate and framework is that organizations must prioritize the security-first identity solutions that will shield them from today's attacks and prepare them for tomorrow's threats."

"NIST CSF 2.0 was created because the U.S. government recognizes that organizations' defenses aren't keeping pace with threats," said RSA Chief Product and Technology Officer Jim Taylor. "NIST doesn't make recommendations lightly, and right now they're recommending that all organizations prioritize deeper security and broader capabilities to defend against phishing, ransomware, cloud account take-over, and other attacks. Just as importantly, CSF 2.0 shows them how to implement those regulations and make NIST's framework a practical reality."

RSA recently released new implementation guidance for NIST CSF 2.0. RSA solutions provide a security-first unified identity platform that secures the full identity lifecycle and helps organizations align with NIST CSF 2.0, meet the presidential mandate, and comply with new CISA requirements:

Resources

NIST CSF 2.0 Implementation Guidance

RSA Public Sector page

About RSA

The AI-powered RSA Unified Identity Platform protects the world's most secure organizations from today's and tomorrow's highest-risk cyberattacks. RSA provides the identity intelligence, authentication, access, governance, and lifecycle capabilities needed to prevent threats, secure access, and enable compliance. More than 9,000 security-first organizations trust RSA to manage more than 60 million identities across on-premises, hybrid, and multi-cloud environments. For more information, go to RSA.com.


These press releases may also interest you

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

18 mai 2024
"Maximizing customer retention and expansion is more important than ever for B2B SaaS companies," said Steven Forth, CEO of Ibbaka. "Our...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

18 mai 2024
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...

18 mai 2024
After tens of thousands of NYC children were turned away from "Summer Rising," New York City's popular, free summer enrichment program, Brains & Motion launched a campaign offering camps at NYU for a small fraction of the up-to-$1400 per week price...



News published on and distributed by: